Sophie Cnudde

Mrs. Sophie Cnudde

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2021 in Science
Verified
Journal Article
Closed access
Federico GulluniFederico Gulluni
Federico Gulluni
LPLorenzo Prever
Lorenzo Prever
HLHuayi Li
Huayi Li
PKPetra Krafcikova
Petra Krafcikova
ICIlaria Corrado
Ilaria Corrado
EHEmilio Hirsch
Emilio Hirsch
ESCRTing lenses away from senescence: ESCRT proteins control membrane fusion in various key cellular processes, but the mechanisms involved are still incompletely understood. Gulluni et al . report that ESCRT recruitment at the cytokinetic bridge is mediated by the binding of an ESCRT-II subunit to the signaling lipid phosphatidylinositol 3,4-bisphosphate (see the Perspective by Brill and Wilde). This pathway acts in parallel to a known cascade driven by a protein called ALIX, but its failure is sufficient to lead to premature senescence in the lens of fish, mouse, and human eyes, where ALIX is expressed at lower levels. These results point to an evolutionarily conserved pathway for the cell-specific control of cytokinesis that serves to protect from senescence and the early onset of cataracts. —SMH

Verified
Journal Article
Open access
PDF file
Nicola MoroNicola Moro
Nicola Moro
LDLolita Dokshokova
Lolita Dokshokova
IVInduja Perumal Vanaja
Induja Perumal Vanaja
VPValentina Prando
Valentina Prando
SCSophie Cnudde
Sophie Cnudde
Tania ZagliaTania Zaglia
Tania Zaglia
Doxorubicin (DOXO) remains amongst the most commonly used anti-cancer agents for the treatment of solid tumors, lymphomas, and leukemias. However, its clinical use is hampered by cardiotoxicity, characterized by heart failure and arrhythmias, which may require chemotherapy interruption, with devastating consequences on patient survival and quality of life. Although the adverse cardiac effects of DOXO are consolidated, the underlying mechanisms are still incompletely understood. It was previously shown that DOXO leads to proteotoxic cardiomyocyte (CM) death and myocardial fibrosis, both mechanisms leading to mechanical and electrical dysfunction. While several works focused on CMs as the culprits of DOXO-induced arrhythmias and heart failure, recent studies suggest that DOXO may also affect cardiac sympathetic neurons (cSNs), which would thus represent additional cells targeted in DOXO-cardiotoxicity. Confocal immunofluorescence and morphometric analyses revealed alterations in SN innervation density and topology in hearts from DOXO-treated mice, which was consistent with the reduced cardiotropic effect of adrenergic neurons in vivo. Ex vivo analyses suggested that DOXO-induced denervation may be linked to reduced neurotrophic input, which we have shown to rely on nerve growth factor, released from innervated CMs. Notably, similar alterations were observed in explanted hearts from DOXO-treated patients. Our data demonstrate that chemotherapy cardiotoxicity includes alterations in cardiac innervation, unveiling a previously unrecognized effect of DOXO on cardiac autonomic regulation, which is involved in both cardiac physiology and pathology, including heart failure and arrhythmias.

1 March 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
VSValentina Sala
Valentina Sala
SCSophie Cnudde
Sophie Cnudde
AMAlessandra Murabito
Alessandra Murabito
AMAlberto Massarotti
Alberto Massarotti
EHEmilio Hirsch
Emilio Hirsch
AGAlessandra Ghigo
Alessandra Ghigo